Spring Creek Capital’s Orthofix Medical OFIX Stock Holding History

Spring Creek Capital’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-6,400	Closed	-$364K	–	475
2018 Q2	$364K	Buy	+6,400	New	+$364K	0.04%	548

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Spring Creek Capital's OFIX Position: Q3 2018 in Review

Spring Creek Capital sold out of Orthofix Medical (OFIX) in Q3 2018, closing a stake of 6,400 shares — an estimated $364K sold.

Spring Creek Capital first reported a position in OFIX in Q2 2018 and held it in 1 quarter. The position peaked at $364K in Q2 2018. 162 funds tracked by Wall St. Rank hold OFIX as of Q3 2018.

Spring Creek Capital reported no remaining Orthofix Medical position as of Q3 2018 after selling out during the quarter.
Spring Creek Capital sold 6,400 Orthofix Medical shares in Q3 2018, an estimated $364K.
Spring Creek Capital first reported a position in Orthofix Medical in Q2 2018 and held it in 1 quarter.
Spring Creek Capital's Orthofix Medical position peaked at $364K in Q2 2018.
162 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2018.

Based on Spring Creek Capital's 13F filing for Q3 2018, filed 13 Nov 2018.